See All Slides - tctmd.com

Slides

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

Presenter: William Lombardi

October 28, 2013

Presentation TCT 2013

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Presenter: Eugene Blackstone

October 28, 2013

Presentation TCT 2013

Evidence Synthesis and Lessons Learned: The DK Crush Trials

Presenter: Shao Liang Chen

October 28, 2013

Presentation TCT 2013

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Risk Stratification and When to Cath

Presenter: Kevin Beatt

October 28, 2013

Presentation TCT 2013

Case Examples(2)

Presenter: Joerg Kempfert

October 28, 2013

Presentation TCT 2013

No Approved BTK Devices in the United States: What Does a Pivotal Device Trial with a Half-chance for Success Look Like?

Presenter: Krishna Rocha-Singh

October 28, 2013

Presentation TCT 2013

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

No! Aspirin and Ticagrelor Is a Much Better Option

Presenter: Emmanouil Brilakis

October 28, 2013

Advertisement

Slides

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Case #8: Why I Attempted an RCA CTO Five Times (And What I Did Different to Succeed)

PARTNER: A Propensity-Matched Comparison of Clinical Outcomes After Transapical vs. Transfemoral TAVR

Evidence Synthesis and Lessons Learned: The DK Crush Trials

Failure Due to Metallic Cage Jail: How Much Does Impaired Vasoreactivity, Conformability, Compliance Mismatch and Other Mechanisms Contribute to Restenosis and Stent Thrombosis?

Risk Stratification and When to Cath

Case Examples(2)

No Approved BTK Devices in the United States: What Does a Pivotal Device Trial with a Half-chance for Success Look Like?

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

No! Aspirin and Ticagrelor Is a Much Better Option

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content